Steven D. Averbuch
Observed names: S Averbuch, S D Averbuch, S. Averbuch, S. D. Averbuch, S.D. Averbuch, SD Averbuch, STEVEN D. AVERBUCH, Steve Averbuch, Steve D. Averbuch, Steven Averbuch, Steven D Averbuch
Observed institutions: AstraZeneca (United Kingdom), Northwestern University, University of Southern California, Merck & Co., Inc., Rahway, NJ, USA (United States), National Institutes of Health, Beth Israel Deaconess Medical Center, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Uniformed Services University of the Health Sciences, University of Alberta, University of California, San Francisco, Wayne State University, Reading Hospital, UW Health University Hospital, Maastricht University Medical Centre, Universitair Ziekenhuis Leuven, Peter MacCallum Cancer Centre, Churchill Hospital, Institut Gustave Roussy, Osaka City University, University of Chicago, The Barbara Ann Karmanos Cancer Institute, Bristol-Myers Squibb (United States), Infinity Pharmaceuticals (United States), Birmingham and Midland Eye Centre, Royal Marsden Hospital, Vall d'Hebron Hospital Universitari, The Christie Hospital, National Cancer Institute, Shikoku Cancer Center, AstraZeneca (United States), Hospital Universitari Germans Trias i Pujol, Japanese Foundation For Cancer Research, Kanagawa Cancer Center, Vanderbilt-Ingram Cancer Center, Rutgers Cancer Institute, Kindai University, Tokushima University, Icahn School of Medicine at Mount Sinai
ORCID: 0000-0002-0210-5901
Observed ORCID: 0000-0002-0210-5901
OpenAlex ID: A5000660231